Identification of serum microRNAs as potential biomarkers in Pompe disease.

Ana Carrasco-RozasEsther Fernández-SimónMaria Cinta LleixàIzaskun BelmonteIrene Pedrosa-HernandezElena Montiel-MorilloClaudia Nuñez-PeraltaJaume Llauger RosselloSonia SegoviaNoemí De LunaXavier Suarez-CalvetIsabel Illanull nullJordi Díaz-ManeraEduard Gallardo

Published in: Annals of clinical and translational neurology (2019)

Serum expression levels of dystromirs may represent additional biomarkers for the follow-up of AOPD patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
poor prognosis
late onset
prognostic factors
patient reported outcomes
binding protein
early onset
patient reported